179 related articles for article (PubMed ID: 32683647)
21. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior.
Revilla G; Al Qtaish N; Caruana P; Sainz-Ramos M; Lopez-Mendez T; Rodriguez F; Paez-Espinosa V; Li C; Vallverdú NF; Edwards M; Moral A; Pérez JI; Escolà-Gil JC; Pedraz JL; Gallego I; Corcoy R; Céspedes MV; Puras G; Mato E
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002329
[TBL] [Abstract][Full Text] [Related]
22. Effect of folic acid-linked chitosan-coated PLGA-based curcumin nanoparticles on the redox system of glioblastoma cancer cells.
Ghoreyshi N; Ghahremanloo A; Javid H; Homayouni Tabrizi M; Hashemy SI
Phytochem Anal; 2023 Dec; 34(8):950-958. PubMed ID: 37463671
[TBL] [Abstract][Full Text] [Related]
23. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
[TBL] [Abstract][Full Text] [Related]
24. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
[TBL] [Abstract][Full Text] [Related]
25. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
26. Chitosan Oleate Salt as an Amphiphilic Polymer for the Surface Modification of Poly-Lactic-Glycolic Acid (PLGA) Nanoparticles. Preliminary Studies of Mucoadhesion and Cell Interaction Properties.
Miele D; Rossi S; Sandri G; Vigani B; Sorrenti M; Giunchedi P; Ferrari F; Bonferoni MC
Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30445668
[TBL] [Abstract][Full Text] [Related]
27. Esterase-responsive and size-optimized prodrug nanoparticles for effective intracranial drug delivery and glioblastoma treatment.
Ye Z; Gao L; Cai J; Wang Y; Li Y; Tong S; Yan T; Sun Q; Qi Y; Xu Y; Jiang H; Zhang S; Zhao L; Zhang S; Chen Q
Nanomedicine; 2022 Aug; 44():102581. PubMed ID: 35811067
[TBL] [Abstract][Full Text] [Related]
28. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
29. Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment.
Ahmad S; Khan I; Pandit J; Emad NA; Bano S; Dar KI; Rizvi MMA; Ansari MD; Aqil M; Sultana Y
Int J Biol Macromol; 2022 Nov; 221():435-445. PubMed ID: 36067850
[TBL] [Abstract][Full Text] [Related]
30. Cherry Extract from
Beconcini D; Fabiano A; Di Stefano R; Macedo MH; Felice F; Zambito Y; Sarmento B
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30974730
[TBL] [Abstract][Full Text] [Related]
31. Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells.
Ramalho MJ; Bravo M; Loureiro JA; Lima J; Pereira MC
Life Sci; 2022 May; 296():120435. PubMed ID: 35247437
[TBL] [Abstract][Full Text] [Related]
32. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
33. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
Ma W; Chen M; Kaushal S; McElroy M; Zhang Y; Ozkan C; Bouvet M; Kruse C; Grotjahn D; Ichim T; Minev B
Int J Nanomedicine; 2012; 7():1475-87. PubMed ID: 22619507
[TBL] [Abstract][Full Text] [Related]
34. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
[TBL] [Abstract][Full Text] [Related]
35. Improving cellular uptake and cytotoxicity of chitosan-coated poly(lactic-
Van Hees S; Elbrink K; De Schryver M; Delputte PL; Kiekens F
Nanomedicine (Lond); 2020 Nov; 15(27):2671-2688. PubMed ID: 33112210
[No Abstract] [Full Text] [Related]
36. Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety.
Chatzitaki AT; Jesus S; Karavasili C; Andreadis D; Fatouros DG; Borges O
Int J Pharm; 2020 Nov; 589():119776. PubMed ID: 32818538
[TBL] [Abstract][Full Text] [Related]
37. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
39. Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents.
Musumeci T; Serapide MF; Pellitteri R; Dalpiaz A; Ferraro L; Dal Magro R; Bonaccorso A; Carbone C; Veiga F; Sancini G; Puglisi G
Eur J Pharm Biopharm; 2018 Dec; 133():309-320. PubMed ID: 30399400
[TBL] [Abstract][Full Text] [Related]
40. Validation of an innovative analytical method for simultaneous quantification of alpha-cyano-4-hydroxycinnamic acid and the monoclonal antibody cetuximab using HPLC from PLGA-based nanoparticles.
Ferreira NN; Boni FI; Baltazar F; Gremião MPD
J Pharm Biomed Anal; 2020 Oct; 190():113540. PubMed ID: 32846401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
